Safety and Efficacy of Adding Ribavirin to Interferon or Peginterferon in Treatment of Hepatitis C Infection in Patients With Thalassemia: A Systematic Review on Randomized Controlled Trials
Conclusions: Compared with monotherapy, adding ribavirin to treatment is more effective in removing hepatitis C virus from the bloodstream in patients with thalassemia, it is also more effective in reducing the relapse rate after treatment. Except the increase in blood transfusion, there was no significant increase in side effects followed by adding ribavirin.
Source: Hepatitis Monthly - Category: Infectious Diseases Source Type: research
More News: Anemia | Blood Transusion | Clinical Trials | Databases & Libraries | Hepatitis | Hepatitis C | Infectious Diseases | Liver | Urology & Nephrology | Virology